Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-17-006064
Filing Date
2017-04-19
Accepted
2017-04-19 06:49:56
Documents
1
Period of Report
2017-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3884
  Complete submission text file 0001179110-17-006064.txt   5318
Mailing Address ONE EMBARCADERO CENTER SUITE 3700 SAN FRANCISCO CA 94111
Business Address
JANNEY DANIEL (Reporting) CIK: 0001198325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 17768106

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations